AbbVie Non-GAAP EPS of $2.16 misses by $0.10, revenue of $15.1B beats by $270M
- AbbVie press release (NYSE:ABBV): Q4 Non-GAAP EPS of $2.16 misses by $0.10.
- Revenue of $15.1B (+5.6% Y/Y) beats by $270M.
- AbbVie is issuing its adjusted diluted EPS guidance for the full-year 2025 of $12.12 to $12.32 vs. $10.39 consensus. The company’s 2025 adjusted diluted